Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
13.00
+0.08 (0.62%)
At close: Apr 23, 2025, 4:00 PM
12.68
-0.32 (-2.46%)
Pre-market: Apr 24, 2025, 6:31 AM EDT
Syndax Pharmaceuticals Employees
Syndax Pharmaceuticals had 270 employees as of December 31, 2024. The number of employees increased by 86 or 46.74% compared to the previous year.
Employees
270
Change (1Y)
86
Growth (1Y)
46.74%
Revenue / Employee
$87,704
Profits / Employee
-$1,180,585
Market Cap
1.12B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
SNDX News
- 19 days ago - Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 22 days ago - Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum - GlobeNewsWire
- 7 weeks ago - Syndax Pharmaceuticals, Inc. (SNDX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Syndax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Syndax Announces Participation in March Investor Conferences - GlobeNewsWire
- 2 months ago - Syndax to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call and Webcast on March 3, 2025 - GlobeNewsWire
- 2 months ago - Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm - GlobeNewsWire
- 3 months ago - Syndax Announces Participation in February Investor Conferences - PRNewsWire